| Title |
Author |
Type |
Date |
Words |
| A Functional Medicine approach to osteoporosis. |
CM Guest Columnist |
|
Feb 1, 2021 |
215 |
| Clinical effect of Zoledronic Acid in the treatment of Senile Osteoporosis. |
Li Kong, Kai Zuo and Long Ma |
|
Dec 31, 2020 |
2613 |
| Osteoporosis drugs don't worsen COVID-19 risk, may help. |
Tucker, Miriam E. |
Clinical report |
Dec 1, 2020 |
819 |
| Osteoporosis drugs don't worsen COVID-19 risk, may help. |
Tucker, Miriam E. |
|
Dec 1, 2020 |
527 |
| New osteoporosis drug approved for us in Scotland; A new drug to treat women with severe cases of the bone disease osteoporosis has been approved for routine use in the NHS in Scotland. |
Laura Paterson |
|
Nov 9, 2020 |
251 |
| Italy's regulatory body clears trial of osteoporosis drug to treat COVID-19. |
|
|
Oct 27, 2020 |
272 |
| Italy's regulatory body clears trial of osteoporosis drug to treat COVID-19. |
|
|
Oct 27, 2020 |
276 |
| Atypical fractures with bisphosphonates highest in Asians. |
Melville, Nancy A. |
|
Sep 1, 2020 |
760 |
| Delaying dose of denosumab ups vertebral fracture risk. |
Dotinga, Randy |
|
Aug 1, 2020 |
804 |
| Osteopenia and osteoporosis among treatment-experienced people living with HIV. |
Lara, Barbara Marques de Castro; de Pddua, Cristiane Menezes; Mendicino, Cassia Cristina Pinto; Roch |
|
Jul 1, 2020 |
6080 |
| Swimming as Treatment for Osteoporosis: A Systematic Review and Meta-analysis. |
Su, Yanlin; Chen, Zhe; Xie, Wei |
Report |
May 31, 2020 |
5276 |
| Algorithm could better osteoporosis Tx. |
Kling, Jim |
|
May 1, 2020 |
612 |
| Association between Hypertension, Antihypertensive Drugs, and Osteoporosis in Postmenopausal Syrian Women: A Cross-Sectional Study. |
Hijazi, Nermeen; Alourfi, Zaynab |
Clinical report |
Mar 31, 2020 |
3496 |
| Treatment Adherence Levels and Factors Affecting Adherence in Patients Receiving Osteoporosis Treatment. |
Kilit, Turkan Pasali; Onbasi, Kevser; Ozyigit, Filiz |
Survey |
Mar 1, 2020 |
4087 |
| All You Need to Know About Osteoporosis Drugs: We look at how these drugs work and the precautions you need to follow when you're taking them. |
|
|
Feb 26, 2020 |
1089 |
| Drugs For Hormonal Replacement Therapy Market Rising Demand, Health Benefits & In-depth Region-Specific Analysis By 2020 / Key Players: Novartis, Bayer, Pfizer & Novo Nordisk / Radiant Insights, Inc. |
|
|
Dec 20, 2019 |
1018 |
| Bone Health. |
Goldstein, Steven R. |
|
Dec 1, 2019 |
3237 |
| Amgen and UCB announce positive CHMP opinion for EVENITY programme for treatment of severe osteoporosis in postmenopausal women. |
|
|
Oct 18, 2019 |
282 |
| Amgen and UCB announce positive CHMP opinion for EVENITY programme for treatment of severe osteoporosis in postmenopausal women. |
|
|
Oct 18, 2019 |
278 |
| Fly Intel: Pre-market Movers. |
|
|
Oct 7, 2019 |
216 |
| Can we discern optimal long-term osteoporosis treatment for women? The use of osteoporosis drugs in sequence--rather than a single agent for a long time--may be the most effective management strategy. |
McClung, Michael R. |
|
Oct 1, 2019 |
1098 |
| Consider drug treatment in late-life women with osteoporosis, regardless of comorbidities. |
Cimino, Steve |
|
Sep 1, 2019 |
430 |
| Rethinking osteoporosis treatment for older patients. |
|
|
Sep 1, 2019 |
259 |
| Medicinal Plants for the Treatment of Postmenopausl Osteoporosis. |
Sharon, S. Evelyn; Chitra, V. |
|
Sep 1, 2019 |
9250 |
| The Effectiveness and Safety of Acupoint Catgut Embedding for the Treatment of Postmenopausal Osteoporosis: A Systematic Review and Meta-Analysis. |
Huang, Fan; Xie, Yumin; Zhao, Siyi; Feng, Zitong; Chen, Guizhen; Xu, Yunxiang |
|
Aug 31, 2019 |
10042 |
| Sandoz enrols first patient in osteoporosis biosimilar drug trial. |
|
|
Jul 24, 2019 |
222 |
| Sandoz enrols first patient in osteoporosis biosimilar drug trial. |
|
|
Jul 24, 2019 |
218 |
| Novartis Unit Sandoz Enrols First Patient In Osteoporosis Drug Trial. |
|
|
Jul 22, 2019 |
220 |
| Evenity gets FDA approval for treating osteoporosis. |
Palmer, Christopher |
|
Jun 1, 2019 |
288 |
| Auranofin Inhibits RANKL-Induced Osteoclastogenesis by Suppressing Inhibitors of [kappa]B Kinase and Inflammasome-Mediated Interleukin-1[beta] Secretion. |
Kim, Hyun Young; Kim, Kyeong Seok; Kim, Myung Ji; Kim, Hyung-Shik; Lee, Kwang-Youl; Kang, Keon Wook |
|
May 31, 2019 |
6057 |
| Bone-Building Meds Battle Osteoporosis: These drugs stimulate new bone growth, making them powerful weapons against advanced osteoporosis. |
Koinis, Thomas F. |
|
May 1, 2019 |
728 |
| The Status of Assessments and Treatments for Osteoporosis in Patients 5 Years after Total Hip Arthroplasty: A Cross-Sectional Survey of 194 Post-THA Patients. |
Kamo, Keiji; Kijima, Hiroaki; Okuyama, Koichiro; Yamada, Shin; Konishi, Natsuo; Kubota, Hitoshi; Taz |
Survey |
Apr 30, 2019 |
2427 |
| Amgen markets EVENITY in the US for the treatment of osteoporosis. |
|
|
Apr 16, 2019 |
273 |
| Amgen markets EVENITY in the US for the treatment of osteoporosis. |
|
|
Apr 16, 2019 |
269 |
| Amgen (NASDAQ: AMGN) - FDA Approves EVENITY[TM] (romosozumab-aqqg) For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk For Fracture -- 9/4/2019. |
|
|
Apr 16, 2019 |
1231 |
| Amgen (NASDAQ: AMGN) - FDA Approves EVENITY[TM] (romosozumab-aqqg) For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk For Fracture -- 9/4/2019. |
|
|
Apr 11, 2019 |
1232 |
| Amgen (NASDAQ: AMGN) - Amgen Presents New Data At WCO-IOF-ESCEO 2019 Revealing Osteoporosis Treatment Gap In Europe -- 7/4/2019. |
|
|
Apr 11, 2019 |
427 |
| Amgen & UCB partnership wins US FDA approval for EVENITY (romosozumab-aqqg) to treat osteoporosis in postmenopausal women. |
|
|
Apr 10, 2019 |
297 |
| Amgen & UCB partnership wins US FDA approval for EVENITY (romosozumab-aqqg) to treat osteoporosis in postmenopausal women. |
|
|
Apr 10, 2019 |
293 |
| Amgen says FDA approves EVENITY for treatment of osteoporosis. |
|
|
Apr 9, 2019 |
229 |
| Amgen presents new data revealing Osteoporosis treatment gap in Europe. |
|
|
Apr 7, 2019 |
202 |
| Osteoporosis drug can prevent bone fractures in elderly women: Study. |
|
|
Oct 7, 2018 |
324 |
| ASK DR. ZAND. |
|
|
Oct 1, 2018 |
575 |
| Osteoporosis Drugs Market to Showcase Healthy Expansion at US$ 14.8 Billion During 2022. |
|
|
Sep 29, 2018 |
231 |
| Strontium ranelate as a possible disease-modifying osteoarthritis drug: a systematic review. |
Rodrigues, T.A.; Freire, A.O.; Bonfim, B.F.; Cartagenes, M.S.S.; Garcia, J.B.S. |
Report |
Aug 1, 2018 |
6400 |
| Drop in Osteoporosis Treatment Initiation After Hip Fracture; Adherence to regimen needed to cut subsequent fracture risk. |
|
|
Jul 27, 2018 |
260 |
| US FDA approves Amgen's use of Prolia. |
|
|
May 22, 2018 |
267 |
| US FDA approves Amgen's use of Prolia. |
|
|
May 22, 2018 |
263 |
| Osteoporosis drug may protect your heart, too. |
|
|
May 12, 2018 |
265 |
| Osteoporosis drug may help reduce heart diseases. |
|
|
May 12, 2018 |
278 |
| Fx Risk Should Be Monitored in Bisphosphonate Drug Holiday; Lower femoral neck bone mineral density and T scores for fracture versus non-fracture group. |
|
|
May 11, 2018 |
271 |
| Osteoporosis drug emerges as possible cure for baldness. |
|
|
May 10, 2018 |
317 |
| Osteoporosis drug emerges as possible cure for baldness. |
|
|
May 10, 2018 |
313 |
| Brittle bone pill is cure for baldness; Drug tested on chrome dome donors' follicles. |
|
|
May 9, 2018 |
174 |
| Osteoporosis treatment preferences and satisfaction in postmenopausal women: Denosumab compared with oral bisphosphonates. |
Baiger, Boguslawa |
Report |
Mar 1, 2018 |
5474 |
| Amgen submits EVENITY's MAA with EMA for the treatment of osteoporosis in women and men. |
|
|
Jan 8, 2018 |
290 |
| Amgen submits EVENITY's MAA with EMA for the treatment of osteoporosis in women and men. |
|
|
Jan 8, 2018 |
286 |
| Adverse Effects of Proton Pump Inhibitors on Platelet Count: A Case Report and Review of the Literature. |
Mukherjee, Subhajit; Jana, Tanima; Pan, Jen-Jung |
Drug overview |
Jan 1, 2018 |
3348 |
| Endocrinologists critique the ACP's osteoporosis treatment guideline. |
Kling, Jim |
|
Oct 15, 2017 |
990 |
| Osteoporosis drugs linked to a rare form of fracture: prolonged use of bisphosphonates raises the risk of side effects. |
|
|
Oct 1, 2017 |
783 |
| Bone building agent. |
|
|
Jul 1, 2017 |
157 |
| Severe right hip pain: while this patient had osteoporosis, she hadn't experienced any recent trauma or falls that would explain her pain. |
Trace, Anthony P.; Hoang, Kimberly; McMonagle, Joseph S. |
Case study |
Jun 1, 2017 |
1325 |
| Evidence supports safety of osteoporosis medication. |
|
|
May 1, 2017 |
143 |
| The Tissue-Selective Estrogen Complex (Bazedoxifene/Conjugated Estrogens) for the Treatment of Menopause. |
Lello, Stefano; Capozzi, Anna; Scambia, Giovanni |
Report |
Jan 1, 2017 |
7403 |
| Corrigendum to "A Clinical Decision Support System for the Diagnosis, Fracture Risks and Treatment of Osteoporosis". |
Halldorsson, Bjarni V.; Bjornsson, Aron Hjalti; Gudmundsson, Haukur Tyr; Birgisson, Elvar Orn; Ludvi |
Correction notice |
Jan 1, 2017 |
341 |
| Fluoxetine appears safer for bone health in at-risk older patients. |
Karon, Amy |
|
Oct 1, 2016 |
564 |
| Merck to cease development of Odanacatib osteoporosis drug. |
|
|
Sep 5, 2016 |
130 |
| Merck to cease development of Odanacatib osteoporosis drug. |
|
|
Sep 5, 2016 |
126 |
| Guidelines for osteoporosis medications call for a 'drug holiday': for women who do not have a high fracture risk, a break from bisphosphonate drugs is advised. |
|
|
Sep 1, 2016 |
632 |
| Should the cardiac rhythm be monitored following administration of zoledronic acid in elderly osteoporotic women?/Yasli osteoporotik kadinlarda zoledronik asit uygulamasi sonrasi kalp ritmi takip edilmeli midir? |
Guzelant, Aliye Yildirim; Sarifakioglu, Ayse Banu; Yilmaz, Ibrahim; Alpsoy, Seref; Saracoglu, Gamze |
Report |
Sep 1, 2016 |
4770 |
| Amgen & UCB submits Romosozumab's BLA to the US FDA for the treatment of osteoporosis in postmenopausal women. |
|
|
Jul 22, 2016 |
293 |
| Amgen & UCB submits Romosozumab's BLA to the US FDA for the treatment of osteoporosis in postmenopausal women. |
|
|
Jul 22, 2016 |
289 |
| Fracture patients often receive no advice about osteoporosis treatment. |
|
|
Jul 1, 2016 |
171 |
| Airport did not supply hoist I booked so I carried my disabled wife on to plane... Outrage over treatment of osteoporosis victim Ann, 58. |
|
Disease/Disorder overview |
Jun 27, 2016 |
354 |
| New Market Research Report: Global Postmenopausal Osteoporosis Drugs Market 2016-2020. |
|
|
May 24, 2016 |
481 |
| Romosozumab marks recent high point in osteoporosis field. |
Jancin, Bruce |
|
Mar 15, 2016 |
474 |
| Effect of Long-Term Use of Bisphosphonates on Forearm Bone: Atypical Ulna Fractures in Elderly Woman with Osteoporosis. |
Erdem, Yusuf; Atbasi, Zafer; Emre, Tuluhan Yunus; Kavadar, Gulis; Demiralp, Bahtiyar |
Case study |
Jan 1, 2016 |
1923 |
| Osteoporosis treatment can be highly effective if used as prescribed. |
|
|
Dec 1, 2015 |
146 |
| Market Report, "Osteoporosis Drugs Market in BRIC Nations 2015-2019", published. |
|
|
Sep 25, 2015 |
544 |
| New osteoporosis drug in the pipeline. |
|
|
Jul 1, 2015 |
153 |
| Laying the groundwork for potential osteoporosis treatment. |
|
|
Jun 22, 2015 |
347 |
| I don't understand why you continue to promote the use of strontium ranelate for osteoporosis prevention or treatment. |
Fuchs, Nan Kathryn |
|
Jun 1, 2015 |
285 |
| Wrist fractures and osteoporosis ... drug alternatives for atrial fibrillation. |
|
|
Jun 1, 2015 |
459 |
| Uni-Bio Science Group's NDA for Osteoporosis Drug Uni-PTH Accepted for Review by CFDA. |
|
|
Apr 8, 2015 |
816 |
| Ask Dr. Nan. |
Nan |
Column |
Apr 1, 2015 |
593 |
| New Market Research Report: Osteoporosis Drugs Market in the APAC Region 2015-2019. |
|
|
Jan 1, 2015 |
575 |
| Osteoporosis medication use down in older women. |
Franki, Richard |
|
Jan 1, 2015 |
215 |
| INADEQUATE DIAGNOSIS, TREATMENT IN MEN FOR OSTEOPOROSIS. |
|
|
Dec 1, 2014 |
128 |
| The most effective drugs for osteoporosis: bisphosphonates are the most commonly prescribed medications, but there are a few alternatives. |
|
|
Aug 1, 2014 |
668 |
| Get informed about Osteoporosis drugs. |
|
|
Jul 1, 2014 |
797 |
| Uni-Bio Science Group's Osteoporosis Drug Uni-PTH Meets Phase III Primary Endpoint. |
|
|
Jun 30, 2014 |
482 |
| Mylan unveils generic US FDA approved Actonel Tablets, 150 mg, for treating osteoporosis in postmenopausal women. |
|
|
Jun 12, 2014 |
141 |
| Mylan unveils generic US FDA approved Actonel Tablets, 150 mg, for treating osteoporosis in postmenopausal women. |
|
|
Jun 12, 2014 |
137 |
| The safety of osteoporosis medication. |
Hough, F.S.; Brown, S.L.; Cassim, B.; Davey, M.R.; de Lange, W.; de Villiers, T.J.; Ellis, G.C.; Lip |
Report |
Apr 1, 2014 |
4274 |
| Experimental drug may change the treatment of osteoporosis: romosozumab appears to increase bone mineral density and help rebuild the skeleton at the same time. |
|
|
Apr 1, 2014 |
674 |
| Verification of osteoporotic vertebral fractures caused by glucocorticoids/Verifikacija vertebralnih osteoporoticnih preloma uzrokovanih glikokortikoidima. |
Jankovic, Tanja; Svorcan, Jelena Zvekic; Boskovic, Ksenija |
Case study |
Mar 1, 2014 |
2801 |
| To treat osteoporosis, denosumab appears more effective than zoledronate: denosumab has the advantage in building bone density, and has fewer side effects. |
Spratt, Susan E. |
|
Mar 1, 2014 |
822 |
| A guide to osteoporosis medications. |
|
|
Mar 1, 2014 |
900 |
| New drug breakthrough brings Osteoporosis cure closer to reality. |
|
|
Feb 3, 2014 |
261 |
| Strontium for osteoporosis. |
Klotter, Jule |
|
Feb 1, 2014 |
658 |
| Tanshinol attenuates the deleterious effects of oxidative stress on osteoblastic differentiation via Wnt/FoxO3a signaling. |
Yang, Yajun; Su, Yanjie; Wang, Dongtao; Chen, Yahui; Wu, Tie; Li, Gang; Sun, Xuegang; Cui, Liao |
Report |
Jan 1, 2014 |
8684 |
| Alendronate versus raloxifene for postmenopausal women: a meta-analysis of seven head-to-head randomized controlled trials. |
Lin, Tiao; Yan, Shi-Gui; Cai, Xun-Zi; Ying, Zhi-Min; Yuan, Fu-Zhen; Zuo, Xi |
Report |
Jan 1, 2014 |
12092 |
| The efficacy of bisphosphonates in preventing aromatase inhibitor induced bone loss for postmenopausal women with early breast cancer: A systematic review and meta-analysis. |
Anagha, Pooleriveetil Padikkal; Sen, Suchandra |
Report |
Jan 1, 2014 |
5472 |
| Alendronate as an effective treatment for bone loss and vascular calcification in kidney transplant recipients. |
Okamoto, Masanori; Yamanaka, Shintaro; Yoshimoto, Wataru; Shigematsu, Takashi |
Report |
Jan 1, 2014 |
3817 |
| Muscle-based pharmacokinetic modeling of marrow perfusion for osteoporotic bone in females. |
Ma, Heather Ting; Griffth, James F.; Leung, Ping-Chung |
Report |
Jan 1, 2014 |
4431 |
| Study on the role of zoledronic acid in treatment of postmenopausal osteoporosis. |
|
Clinical report |
Dec 31, 2013 |
2729 |
| Osteoporosis treatment at present and in the future/ Gunumuzde ve gelecekte osteoporoz tedavisi. |
Sindel, Dilsad |
Report |
Dec 1, 2013 |
6170 |
| Pfizera[euro](tm)s DUAVEE receives FDA approval for treatment of moderate-to-severe vasomotor symptoms (hot flashes) associated with menopause and the prevention of postmenopausal osteoporosis. |
|
|
Oct 4, 2013 |
299 |
| Anti-Libido Drug Used in WA Prisons on Sex Offenders Has Osteoporosis, Cardiac Problems as Health Risks (VIDEO). |
|
|
Sep 22, 2013 |
192 |
| Repros Therapeutics Inc updates six month bone mineral density data from Study ZA-303 in Androxal subjects, with no bone loss & improving bone mineral density. |
|
|
Aug 21, 2013 |
263 |
| Repros Therapeutics Inc updates six month bone mineral density data from Study ZA-303 in Androxal subjects, with no bone loss & improving bone mineral density. |
|
|
Aug 21, 2013 |
259 |
| A novel approach for high level expression of soluble recombinant human parathyroid hormone (rhPTH 1-34) in Escherichia coli. |
Hamedifar, Haleh; Salamat, Firoozeh; Saffarion, Mohammad; Ghiasi, Mohammad; Hosseini, Alireza; Lahij |
Report |
Jul 1, 2013 |
3951 |
| Too few men receiving prostate cancer treatment are getting bone density scans. |
|
|
Jul 1, 2013 |
183 |
| Current treatment approaches to osteoporosis--2013. |
Honig, Stephen; Rajapakse, Chamith S.; Chang, Gregory |
Report |
Jul 1, 2013 |
3181 |
| Non-pharmacological management of osteoporosis. |
Dolbow, David R.; Gorgey, Ashraf S. |
Clinical report |
Jun 22, 2013 |
2612 |
| Drug to treat osteoporosis prevents growth of breast cancer cells. |
|
|
Jun 16, 2013 |
249 |
| 2-osteoporosis drug combo increases bone density better than single-drug therapy. |
|
|
May 15, 2013 |
292 |
| Headlines & your health: drug cuts fractures in men with osteoporosis. |
|
|
Jan 1, 2013 |
257 |
| New patient decision aid and other resources available on osteoporosis medications. |
|
Brief article |
Jan 1, 2013 |
171 |
| FDA approves new form of osteoporosis medication. |
|
|
Dec 1, 2012 |
118 |
| In the pipeline: A drug that curbs bone resorption without diminishing bone formation. |
Goldstein, Steven R. |
|
Nov 1, 2012 |
428 |
| 1-800 bad drug. |
Gaby, Alan R. |
Editorial |
Jul 1, 2012 |
793 |
| Periodontist Discusses Study Linking Osteoporosis Drug Complications to Patients with Certain Genes. |
|
|
Jun 27, 2012 |
621 |
| Bisphosphonate-related osteonecrosis of the jaw bones in a patient with ankylosing spondylitis receiving anti-tumor necrosis factor treatment / anti-tumor nekroz faktor tedavisi alan ankilozan spondilitli bir olguda gelisen bifosfonatla iliskili cene osteonekrozu. |
Isleten, Banu; Hepguler, Simin; Bayraktaroglu, Selen; Keser, Gokhan |
Report |
Dec 1, 2011 |
2464 |
| New option for osteoporosis treatment. |
|
|
Nov 1, 2011 |
148 |
| Reclast cut fractures by 67% in osteoporotic men. |
Jancin, Bruce |
|
Oct 15, 2011 |
422 |
| Denosumab delivered long-term efficacy. |
Jancin, Bruce |
|
Oct 15, 2011 |
924 |
| Oral calcitonin scores for osteoporosis in phase III. |
Jancin, Bruce |
|
Oct 1, 2011 |
545 |
| Encouragement aids antiresorptive therapy adherence. |
Boschert, Sherry |
Report |
Oct 1, 2011 |
819 |
| Experimental osteoporosis treatments show promise. |
Boschert, Sherry |
|
Sep 15, 2011 |
796 |
| New osteoporosis treatments show promise. |
Boschert, Sherry |
|
Sep 15, 2011 |
676 |
| Servier fakes papers for Protelos drug. |
|
|
Sep 7, 2011 |
154 |
| Lower dose of osteoporosis drug effectively increases bone density: side effects would be minimized by a lower dose but provide the same benefit, research suggests. |
|
|
Sep 1, 2011 |
361 |
| New agents for the treatment of osteoporosis/Osteoporozda yeni tedavi ajanlari. |
Guven, Zeynep; Celiker, Reyhan; Atalay, Ayce; Bagis, Selda |
|
Sep 1, 2011 |
6871 |
| Bone growth gene may lead to new osteoporosis treatments: the Lrp5 gene aids in bone growth and strength as well as bone deterioration, depending on certain mutations. |
Guilak, Farshid |
|
Aug 1, 2011 |
662 |
| New osteoporosis treatment approved. |
|
|
Aug 1, 2011 |
140 |
| Strontium ranelate shows antifracture efficacy over 10 years. |
Zoler, Mitchel L. |
|
Aug 1, 2011 |
905 |
| Low-dose zoledronate bolstered bone density. |
Schonfeld, Amy Rothman |
Report |
Aug 1, 2011 |
573 |
| Osteogenic effects of flavonoid aglycones from an osteoprotective fraction of Drynaria fortunei--an in vitro efficacy study. |
Xinluan, Wang; Lizhen, Zhen; Ge, Zhang; Man-Sau, Wong; Ling, Qin; Xinsheng, Yao |
Report |
Jul 15, 2011 |
3908 |
| Benefits of osteoporosis drugs outweigh risks: bisphosphonates are still beneficial, but taking time off of them after long-term use may alleviate fracture concerns. |
|
|
Jul 1, 2011 |
769 |
| Osteoporosis: new treatments and updates. |
Honig, Stephen |
|
Jul 1, 2011 |
2676 |
| Gene's role in bone growth may lead to new treatment of osteoporosis. |
|
|
May 23, 2011 |
345 |
| Osteoporosis Tx challenges grow with options. |
McNamara, Damian |
|
May 15, 2011 |
621 |
| Effects of Bone-building Drugs. |
|
|
May 6, 2011 |
356 |
| Osteoporosis treatment could extend life by five years. |
|
|
May 1, 2011 |
214 |
| The benefits of osteoporosis treatment outweigh the risks. |
|
|
May 1, 2011 |
971 |
| Denosumab bone benefits persisted after 5 years. |
Splete, Heidi |
|
May 1, 2011 |
486 |
| A controversy: linking atypical femoral fractures to bisphosphonate therapy. |
Trotter, Christopher C.; Pfister, Alfred K.; Whited, Brant A.; Goldberg, Todd H.; Artz, Steven A. |
Clinical report |
Mar 1, 2011 |
2566 |
| Spread the word--osteoporosis drugs cause osteoporosis. |
|
|
Mar 1, 2011 |
629 |
| Osteoporosis drugs' "broken" promise. |
Klebanow, Diana |
|
Mar 1, 2011 |
2525 |
| Long-term use of osteoporosis drugs raises risk of fractures. |
|
|
Feb 24, 2011 |
519 |
| Osteoporosis treatment gives patients an extra 5 years of life. |
|
|
Feb 3, 2011 |
368 |
| Consider denosumab for postmenopausal osteoporosis: easy to use and effective, this recently approved agent appears well suited to ObGyn office practice. |
Barbieri, Robert L. |
Editorial |
Jan 1, 2011 |
1687 |
| Osteoporosis drug may benefit patients with oral cancer. |
|
|
Dec 14, 2010 |
428 |
| Osteoporosis drug improves survival in cancer patients. |
|
|
Dec 4, 2010 |
308 |
| Long-term treatment with bisphosphonates and their side effects in postmenopausal osteoporosis/Postmenopozal osteoporoz tedavisinde uzun donem bifosfonat kullanimi ve gorulebilen yan etkiler. |
Saridogan, Merih; Gun, Kerem |
Report |
Dec 1, 2010 |
3959 |
| Cumulative corticosteroid doses and osteoporosis in patients with multiple sclerosis / Multipl sklerozlu hastalarda kumulatif kortikosteroid dozu ve osteoporoz. |
Arslan, Sule; Celiker, Reyhan; Karabudak, Rana |
Clinical report |
Dec 1, 2010 |
3328 |
| Osteoporosis drugs come under new scrutiny. |
|
|
Nov 1, 2010 |
210 |
| Common osteoporosis drugs linked with esophageal cancer. |
|
|
Nov 1, 2010 |
141 |
| Denosumab outperforms alendronate as well as placebo. |
|
|
Nov 1, 2010 |
1267 |
| Osteonecrosis of the jaw in bisphosphonate users may be more common than we think. |
Goldstein, Steven |
|
Nov 1, 2010 |
391 |
| Bisphosphonates and fractures. |
|
Brief article |
Nov 1, 2010 |
241 |
| Eli Lilly & Co's (Indianapolis IN) osteoporosis drug Forteo can regrow bone in jaws damaged by severe bone-destroying conditions called osteonecrosis and periodontitis, doctors reported. |
|
|
Oct 25, 2010 |
417 |
| New data confirm efficacy, safety of Novartis osteoporosis drug. |
|
|
Oct 18, 2010 |
268 |
| FDA approves Warner Chilcott's ACTONEL for treatment of postmenopausal osteoporosis. |
|
|
Oct 11, 2010 |
101 |
| New research holds promise for development of novel osteoporosis drug. |
|
|
Oct 5, 2010 |
271 |
| Osteoporosis treatment: defining goals, optimizing strategies. |
Lewiecki, E. Michael |
|
Oct 1, 2010 |
3072 |
| New pathways in osteoporosis therapy: a preview of new agents. |
Cummings, Steven R. |
|
Oct 1, 2010 |
1429 |
| Protein could help in treatment of osteoporosis. |
|
|
Sep 28, 2010 |
157 |
| EffRx, Nycomed seek approval for osteoporosis treatment EX101 in Europe. |
|
|
Sep 21, 2010 |
131 |
| Ono, Astellas seek approval for monthly oral osteoporosis treatment in Japan. |
|
|
Sep 10, 2010 |
249 |
| Osteoporosis drug 'doubles cancer risk'. |
|
|
Sep 3, 2010 |
205 |
| New drug for osteoporosis approved. |
|
|
Sep 1, 2010 |
133 |
| Why osteopenia isn't a disease - and you don't need drugs to treat it! |
|
|
Sep 1, 2010 |
1056 |
| New osteoporosis treatment approved. |
|
|
Sep 1, 2010 |
147 |
| Osteoporosis: new treatments and updates. |
Honig, Stephen |
Report |
Jul 1, 2010 |
3284 |
| Aromatase inhibitors and bone health. |
Bundred, Nigel J. |
Clinical report |
Jul 1, 2010 |
4209 |
| Osteoporosis drug approved. |
|
|
Jul 1, 2010 |
109 |
| Osteoporosis drug approved. |
|
Brief article |
Jul 1, 2010 |
109 |
| New drug targets bone destruction pathway. |
Mahoney, Diana |
|
Jun 15, 2010 |
446 |
| Watson seeks FDA nod to market generic EVISTA. |
|
|
May 6, 2010 |
228 |
| Building better bones. |
|
Brief article |
May 1, 2010 |
294 |
| The effects of bisphosphonates used continually or intermittently on fractures, bone mineral density and biochemical parameters in osteoporotic patients/Osteoporozlu hastalarda bifosfonatlarin devamli veya aralikli kullaniminin kirik, kemik yogunlugu ve biyokimyasal parametrelere etkisi. |
Cevikol, Alev; Umay, Ebru; Karaahmet, Ozgur Zeliha; Avluk, Ozlem Celik; Cakci, Aytul |
Report |
Apr 1, 2010 |
5109 |
| Effect of weekly alendronate on knee symptoms in patients with osteoporosis and knee osteoarthritis coexistence/Osteoporoz ve diz osteoartritinin birlikte bulundugu hastalarda diz semptomlari uzerine haftalik alendronatin etkinligi. |
Ediz, Levent; Hiz, Ozcan; Toprak, Murat; Tekeoglu, Ibrahim |
Report |
Apr 1, 2010 |
2953 |
| This osteoporosis drug also stops breast cancer--here's why you shouldn't take it. |
|
|
Apr 1, 2010 |
297 |
| Long-term use of osteoporosis drug may weaken bones. |
|
|
Mar 12, 2010 |
299 |
| Alendronate and calcitonin treatment in osteoporis/Osteoporozda alendronat ve kalsitonin tedavisi. |
Sevgi, Serhan; Esen, Selma; Yilmaz, Figen; Sahin, Fusun; Dogu, Beril; Kuran, Banu |
|
Mar 1, 2010 |
996 |
| The fixed herbal drug composition "Saikokaryukotsuboreito" prevents bone loss with an association of serum IL-6 reductions in ovariectomized mice model. |
Hattori, T.; Fei, W.; Kizawa, T.; Nishida, S.; Yoshikawa, H.; Kishida, Y. |
Report |
Mar 1, 2010 |
5189 |
| Osteoporosis drug may help cut risk of bone fractures, breast cancer, stroke. |
|
|
Feb 25, 2010 |
395 |
| Diabetes drug raises bone fracture risk in older women. |
|
|
Feb 11, 2010 |
167 |
| Approaches to osteoporosis. |
Kent, Athol |
Brief article |
Feb 1, 2010 |
207 |
| Zoledronic acid and bone loss. |
Kent, Athol |
Brief article |
Feb 1, 2010 |
272 |
| Human trial of promising new osteoporosis drug to be launched. |
|
|
Jan 15, 2010 |
310 |
| Fewer breast cancers in bisphosphonate users. |
Bates, Betsy |
Report |
Jan 1, 2010 |
769 |
| Hormone therapy for men safer than presumed. |
Klotter, Jule |
Report |
Jan 1, 2010 |
623 |
| To pill or not to pill. |
Klebanow, Diana |
|
Jan 1, 2010 |
2160 |
| Bisphosphonates may reduce breast cancer risk. |
Bates, Betsy |
|
Jan 1, 2010 |
797 |
| Comparison of effectiveness of strontium ranelate and alendronate sodium in postmenopausal osteoporosis/Postmenopozal osteoporoz tedavisinde stronsiyum ranelat ile alendronat sodyumun etkinliginin karsilasltirilmasi. |
Kaya, Kurtulus; Delialioglu, Sibel Unsal; Ozel, Sumru; Culha, Canan; Kurt, Eda; Ozgonul, Sezen |
Clinical report |
Dec 1, 2009 |
3658 |
| Reducing risk factors for osteoporosis: medication can effectively treat the disease, but lifestyle factors remain important. |
|
|
Dec 1, 2009 |
775 |
| Merck & Co. |
|
|
Nov 30, 2009 |
198 |
| Data lacking on osteoporosis drug. |
|
|
Nov 15, 2009 |
281 |
| Bisphosphonate therapy: when not to monitor BMD: monitoring bone density within the first 3 years of therapy does not provide useful information--and it is costly besides. |
Sharma, Umang; Stevermer, James J.; Hickner, Jihn |
Case study |
Nov 1, 2009 |
1347 |
| Alter bone care in patients on glucocorticoids. |
Wachter, Kerri |
Report |
Nov 1, 2009 |
910 |
| GSK's Cervarix gains approval in Japan: Amgen osteoporosis drug delayed by FDA. |
|
|
Nov 1, 2009 |
1697 |
| New osteoporosis drug in the pipeline: a potential new treatment may have fewer side effects than existing drugs. |
|
|
Nov 1, 2009 |
665 |
| Strontium for Osteoporosis: how much and for how long? |
Gaby, Alan R. |
Clinical report |
Nov 1, 2009 |
597 |
| Denosumab nears FDA approval for treatment of osteoporosis. |
Goldstein, Steven R. |
|
Nov 1, 2009 |
1016 |
| Another SERM bites the dust. |
Goldstein, Steven R. |
|
Nov 1, 2009 |
468 |
| What you can do to improve your bone health: by now you've read about the various treatments available for arthritis, osteoporosis and various joint problems. How about preventing the damage and pain in the first place? |
Peeke, Pamela |
|
Nov 1, 2009 |
551 |
| Top five challenges in osteoporosis Tx. |
Jancin, Bruce |
Clinical report |
Oct 15, 2009 |
714 |
| Denosumab increased BMD in 6-year study. |
Wachter, Kerri |
Clinical report |
Oct 15, 2009 |
603 |
| Glucocorticoids alter bone care dramatically. |
Wachter, Kerri |
Report |
Oct 15, 2009 |
949 |
| Women had 6-year BMD rise with denosumab. |
Wachter, Kerri |
|
Oct 1, 2009 |
638 |
| Current and emerging therapies for osteoporosis. |
Mitchner, Natasha A.; Harris, Steven T. |
Report |
Oct 1, 2009 |
3469 |
| Teriparatide gets extra nod. |
|
|
Sep 15, 2009 |
134 |
| Existing osteoporosis drug may keep joint injuries from causing long-term osteoarthritis. |
|
|
Sep 13, 2009 |
617 |
| Teriparatide gets an extra nod. |
|
|
Sep 1, 2009 |
141 |
| Denosumab's benefits seen to outweigh risks. |
Ault, Alicia |
|
Sep 1, 2009 |
327 |
| BMS/AZ diabetes drug approved: Lilly cancels osteoporosis drug in Phase III. |
|
|
Sep 1, 2009 |
2717 |
| Comparison of the effects of alendronate and calcitonin in postmenopausal osteoporosis/Postmenopozal osteoporozda kemik mineral yogunlugu uzerine alendronat ve kalsitonin etkinliginin karsilastirilmasi. |
Yilmaz, Figen; Sahin, Fusun; Dogu, Beril; Kuran, Banu |
Clinical report |
Sep 1, 2009 |
3759 |
| Strontium ranelate for the treatment of post-menopausal osteoporosis / Postmenopozal osteoporoz tedavisinde stronsiyum ranelat. |
Bozbey, Ismahan; Yalcin, Ayse Peyman |
Report |
Sep 1, 2009 |
4702 |
| Osteoporosis drug shows promise in tests. |
|
Brief article |
Aug 17, 2009 |
266 |
| Amgen reaches deal with GlaxoSmithKline on bone drug. |
|
Brief article |
Aug 3, 2009 |
220 |
| Osteoporosis drug may jumpstart fracture healing. |
|
|
Jul 1, 2009 |
142 |
| Bisphosphonates: bone strengtheners or bone hardeners? |
Lenard, Lane |
|
Jul 1, 2009 |
4803 |
| Amgen to discusses Denosumab data at Advisory Committee for Reproductive Health Drugs. |
|
|
Jul 1, 2009 |
594 |
| Biyearly zoledronic acid gets nod for bone loss prevention. |
Mahoney, Diana |
Brief article |
Jun 15, 2009 |
304 |
| Use of antiepileptics linked to increase in fracture risk. |
London, Susan |
|
Jun 1, 2009 |
447 |
| Corticosteroid-induced bone loss occurs within 3 months. |
Wendling, Patrice |
Report |
May 15, 2009 |
451 |
| Celiac disease predisposes patients to bone loss. |
Sullivan, Michele G. |
Report |
May 15, 2009 |
515 |
| Zoledronic acid tops raloxifene for bone loss. |
Sullivan, Michele G. |
Report |
May 15, 2009 |
522 |
| Aromatase inhibitors may hasten bone loss. |
Sullivan, MIchele G. |
|
May 1, 2009 |
340 |
| Osteoclast inhibitory effects of vitamin K2 alone or in combination with etidronate or risedronate in patients with rheumatoid arthritis: 2-year results. |
|
Report |
May 1, 2009 |
222 |
| Osteoporosis drug can mend hard-to-heal elderly fractures. |
|
|
Apr 15, 2009 |
502 |
| Eli Lilly & Co. |
|
Brief article |
Apr 13, 2009 |
230 |
| Annual dose of osteoporosis drug better than daily to boost brittle bones' strength. |
|
|
Apr 10, 2009 |
366 |
| No link between osteoporosis drugs, irregular heartbeat. |
|
|
Apr 7, 2009 |
235 |
| Relation of Vitamin B12 levels to bone mineral density of postmenopausal women/ Postmenopozal kadinlarin kemik mineral yogunlugunun vitamin B12 duzeyleri ile iliskisi. |
Kesiktas, Nur; Eskiyurt, Nurten; Karan, Ayse; Aki, Semih; Issever, Halim |
Report |
Apr 1, 2009 |
3625 |
| Comparison of the effects of strontium ranelate and raloxiphene on bone mineral density in postmenopausal osteoporosis/ Postmenopozal osteoporozda stronsiyum ranelat de raloksifen'in kemik Mineral yogunlugu uzerindeki etkinliginin karsilastirilmasi. |
Yilmaz, Figen; Dogu, Beril; Sahin, Tulay; Sahin, Fusun; Kuran, Banu |
Report |
Apr 1, 2009 |
2746 |
| NHS osteoporosis drug rethink. |
|
|
Feb 20, 2009 |
254 |
| NHS osteoporosis drug rethink. |
|
|
Feb 19, 2009 |
254 |
| Zoledronic acid an option for osteoporotic men. |
Evans, Jeff |
|
Jan 15, 2009 |
764 |
| The only drug you should ever take for osteoporosis. |
|
|
Jan 1, 2009 |
1136 |
| Cancer treatment leads to bone loss. |
|
|
Dec 3, 2008 |
420 |
| The ovariectomized, mature rat model of postmenopausal osteoporosis: an assessment of the bone sparing effects of curcumin. |
French, D.L.; Muir, J.M.; Webber, C.E. |
Clinical report |
Dec 1, 2008 |
5731 |
| VIBE: evaluation of ibandronate efficacy: a retrospective cohort study comparing fracture rates for women receiving monthly ibandronate vs weekly bisphosphonates presentation of a sub-group analysis excluding patients with osteopenia, alendronate 35mg and corticosteroid use/VIBE: ibandronat'in etkinliginin degerlendirilmesi haftalik bifosfonatlar ve aylik ibandronat.... |
Reginster, J.-Y.; Poston, S. |
Report |
Dec 1, 2008 |
1423 |
| VIBE: evaluation of ibandronate efficacy: a retrospective cohort study comparing fracture rates for women receiving monthly ibandronate vs weekly bisphosphonates presentation of a sub-group analysis excluding patientr with osteopenia, alendronate 35mg and corticosteroid use/VIBE: ibandronat'in etkinliginin degerlendirilmesi: haftalik bifosfonatlar ve aylik ibandronat tedavisinde kadinlarda kirik oranlarini.... |
Reginster, J.-Y.; Poston, S. |
Report |
Dec 1, 2008 |
1282 |
| Does anti-TNF-alpha have a role in the treatment of osteoporosis? |
McMahon, Mark S.; Ueki, Yasuyoshi |
Clinical report |
Dec 1, 2008 |
992 |
| Cancer treatment leads to bone loss. |
|
|
Nov 25, 2008 |
420 |
| Oral bisphosphonates and atrial fibrillation--is there a link? |
|
Clinical report |
Nov 1, 2008 |
549 |
| FDA panel backs lasofoxifene for osteoporosis indication. |
Mechcatie, Elizabeth |
|
Nov 1, 2008 |
827 |
| Alendronate, usually given to women for osteoporosis, is also helpful for men undergoing hormone therapy to fight prostate cancer, a study shows. |
|
Brief article |
Oct 27, 2008 |
230 |
| Bone-breaking drugs? |
Fugh-Berman, Adriane; Massion, Charlea T. |
|
Sep 1, 2008 |
986 |
| Calcium in older women. |
|
Brief article |
Aug 1, 2008 |
287 |
| Comparison of dual energy X-ray absorptiometry and quantitative ultrasonography measurements in osteoporotc patients/Osteoporozlu hastalarda Dual Enerji X-Ray Absorbsiyometri degerleri ile kantitatif ultrasonografi degerlerinin karsilastirilmasi. |
Tutun, Sule; Saylik, Derya; Ozgononel, Levent; Cetin, Esra; Kavadar, Gulis; Tolga, Seyma; Gunaydin, |
Report |
Aug 1, 2008 |
1617 |
| FDA approves generic Fosamax for osteoporosis. |
|
|
Jul 1, 2008 |
156 |
| Fosamax update: the news is worse than ever. |
Fuchs, Nan Kathryn |
|
Jul 1, 2008 |
1190 |
| New guide on osteoporosis treatment, prevention offered. |
|
|
Jun 1, 2008 |
530 |
| New guidelines for osteoporosis prevention, Tx: the national osteoporosis foundation has expanded its guidelines beyond postmenopausal white women. |
Boschert, Sherry |
|
Jun 1, 2008 |
1091 |
| New risks noted for drugs that are widely used for diabetes, osteoporosis. |
Moon, Mary Ann |
|
May 15, 2008 |
604 |
| The silent enemy: no one is immune to osteoporosis--but what can you do about it? A new therapy may help. |
Alonzo, Bob |
|
May 1, 2008 |
1037 |
| Low bone mass frequently gets overtreated. |
Walsh, Nancy |
|
May 1, 2008 |
893 |
| FDA issues advisory about osteoporosis drugs. |
|
|
Mar 1, 2008 |
125 |
| Novel osteoporosis treatments show promise. |
Finn, Robert |
|
Feb 15, 2008 |
609 |
| Bazedoxifene may not harm the endometrium. |
Lowry, Fran |
Brief article |
Dec 1, 2007 |
279 |
| FDA approves Reclast for once-a-year osteoporosis treatment. |
|
|
Nov 1, 2007 |
130 |
| Osteoporosis: recent data refine our understanding of how to use key drugs, particularly bisphosphonates, zoledronic acid, recombinant PTH, and raloxifene. |
Goldstein, Steven R. |
|
Nov 1, 2007 |
311 |
| Ask Dr. Nan. |
Fuchs, Nan Kathryn |
|
Oct 1, 2007 |
628 |
| Treatment of osteoporosis in men helps prevent fracture. |
|
|
Oct 1, 2007 |
164 |
| Panel backs osteoporosis drug for reducing breast ca risk. |
Bullock, Lorinda |
|
Sep 1, 2007 |
495 |
| Panel okays drug to lower breast ca risk. |
Bullock, Lorinda |
|
Aug 15, 2007 |
630 |
| Panel okays drug to cut breast cancer risk in postmenopause. |
Bullock, Lorinda |
|
Aug 15, 2007 |
591 |
| Osteoporosis drug may cause abnormal heart rhythm. |
|
|
Aug 1, 2007 |
151 |
| New weapons in the war on osteoporosis: a wide spectrum of drug therapies now give women with osteoporosis more options and better outcomes. |
|
|
Aug 1, 2007 |
1262 |
| Osteoporosis medications rarely used in nursing homes even after fractures. |
Kirn, Timothy F. |
|
Jul 15, 2007 |
364 |
| Osteoporosis-related fractures costly in elderly: fewer than half of osteoporosis patients received drug treatment, which averaged $500 per patient. |
Wachter, Kerri |
|
Jul 1, 2007 |
641 |
| Teriparatide boosts bone density in secondary osteoporosis. |
Wachter, Kerri |
|
May 15, 2007 |
703 |
| Some women may be able to take a break from osteoporosis drugs. |
|
Brief article |
Feb 1, 2007 |
184 |
| Bisphosphonates. |
|
|
Jan 1, 2007 |
442 |
| Annual bisphosphonate greatly reduces fractures. |
Wachter, Kerri |
|
Dec 1, 2006 |
1057 |
| Periodic ibandronate injections improve BMD at 2 years. |
Wachter, Kerri |
|
Dec 1, 2006 |
451 |
| Sequential Tx sustains benefits of teriparatide in osteoporosis. |
Walsh, Nancy |
|
Nov 1, 2006 |
546 |
| Risedronate gains approval for treating osteoporosis in men. |
Mechcatie, Elizabeth |
Brief article |
Sep 15, 2006 |
300 |
| Pipeline looks full of new osteoporosis therapies. |
Finn, Robert |
|
Sep 15, 2006 |
684 |
| Which, if any, bone-saving drug is best for you? |
|
|
Sep 1, 2006 |
1032 |
| Relative risk data favor acceptance of bisphosphonate Tx. |
Rollins, Jane Neff |
|
Sep 1, 2006 |
349 |
| Zoledronic acid slows bone loss in prostate cancer. |
MacNeil, Jane Salodof |
Disease/Disorder overview |
Aug 1, 2006 |
298 |
| Nasal spray formulation of teriparatide is in the works. |
Wendling, Patrice |
Drug overview |
Jul 15, 2006 |
557 |
| Arvella's Rx for osteoporosis: forteo and exercise. |
SerVaas, Cory |
|
Jul 1, 2006 |
625 |
| BMD gains superior on monthly bisphosphonate. |
Wendling, Patrice |
|
Jul 1, 2006 |
595 |
| New antiresorptive agents may be better tolerated. |
Sullivan, Michele G. |
Drug overview |
Jul 1, 2006 |
606 |
| Don't switch drugs if BMD fails to improve. |
Sullivan, Michele G. |
Brief article |
Jul 1, 2006 |
307 |
| Relative risk data favor benefits of bisphosphonates. |
Rollins, Jane Neff |
|
Jul 1, 2006 |
313 |
| Behind the headlines: osteoporosis drug concerns. |
|
|
Jun 1, 2006 |
871 |
| Novel antiresorptives well tolerated. |
Sullivan, Michele G. |
Drug overview |
Jun 1, 2006 |
732 |
| Don't immediately switch bone agents if BMD fails to improve. |
Sullivan, Michele G. |
Drug overview |
Jun 1, 2006 |
380 |
| Medication burden substantial in women with osteoporosis. |
Brunk, Doug |
|
Apr 1, 2006 |
351 |
| High medication burden seen in women with osteoporosis. |
Brunk, Doug |
|
Mar 15, 2006 |
344 |
| Forteo for osteoporosis. |
SerVaas, Cory |
|
Mar 1, 2006 |
348 |
| FDA approves first IV osteoporosis therapy. |
Mechcatie, Elizabeth |
|
Mar 1, 2006 |
665 |
